Brief: Galera Submits Marketing Application For Oral Mucositis Drug

Obsidian Therapeutics

12/12/2022 15:21

Dec 12 (Reuters) - Galera Therapeutics Inc  GRTX.O :
    * GALERA SUBMITS NEW DRUG APPLICATION FOR AVASOPASEM FOR
SEVERE
ORAL MUCOSITIS
    * GALERA THERAPEUTICS INC- FDA HAS GRANTED FAST TRACK AND
BREAKTHROUGH THERAPY DESIGNATIONS TO AVASOPASEM FOR REDUCTION OF
SOM INDUCED BY RADIOTHERAPY
    * GALERA THERAPEUTICS INC- AVASOPASEM WAS GENERALLY WELL
TOLERATED
COMPARED TO PLACEBO

Source text for Eikon:  ID:nGNX2qq62f 
Further company coverage:  GRTX.O 
 ((Reuters.Briefs@thomsonreuters.com;))